Regional: Prevention and Control of HIV/AIDS and Other Communicable Diseases in Central Asia Regional Economic Cooperation Countries

Sovereign Project | 46096-001

Summary

The impact of the TA is decreased incidence of communicable diseases in participating Central Asian countries, in particular of HIV/AIDS in key population groups at risk and of vaccine-preventable diseases. The outcome of the TA is strengthened core capacity for surveillance and response to communicable diseases in pilot countries in line with the IHR. Strengthening the IHR was identified as the best way to strengthen national and regional health systems in order to improve HIV/AIDS and communicable disease surveillance and control.

Latest Project Documents


Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.

The Public Communications Policy (PCP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.

The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.

In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.

Project Name Prevention and Control of HIV/AIDS and Other Communicable Diseases in Central Asia Regional Economic Cooperation Countries
Project Number 46096-001
Country Regional
Project Status Closed
Project Type / Modality of Assistance Technical Assistance
Source of Funding / Amount
Strategic Agendas Environmentally sustainable growth
Inclusive economic growth
Regional integration
Drivers of Change Governance and capacity development
Partnerships
Sector / Subsector

Health - Health system development

Industry and trade - Industry and trade sector development

Gender Equity and Mainstreaming Gender equity
Description

The impact of the TA is decreased incidence of communicable diseases in participating Central Asian countries, in particular of HIV/AIDS in key population groups at risk and of vaccine-preventable diseases. The outcome of the TA is strengthened core capacity for surveillance and response to communicable diseases in pilot countries in line with the IHR. Strengthening the IHR was identified as the best way to strengthen national and regional health systems in order to improve HIV/AIDS and communicable disease surveillance and control.

Output 1: Mapping of communicable disease vulnerability and response conducted in each participating country. Effective control of communicable diseases requires information and evidence on the vulnerability of its population and geographic hot spots of disease incidence and prevalence. WHO supports member states in mapping potential hazards and vulnerabilities, which allows for development of focused preparedness activities to reduce the impact of crises, and thus prevent them from developing into full-scale disasters. One of the activities in this field has been the development of a disaster vulnerability mapping e-atlas to encourage ministries of health and other stakeholders within the health community to develop and improve their disaster management capacities. This e-atlas will be used as a framework for HIV/AIDS and communicable disease vulnerability mapping in each target country, including mapping of vaccination coverage for measles, rubella, and polio. This will allow the provision of sex-disaggregated and analyzed data for decision making for Central Asian governments and facilitate regional dialogue about cross-border risks from communicable diseases.

Output 2: Improved and standardized communicable disease surveillance and control in participating countries. Central Asian countries endorsed the European Action Plan for HIV/AIDS, 2012 2015, which aims to reduce the number of new HIV infections. However, because of the limited access to and low uptake of HIV testing and counseling services, it is estimated that up to 60% of people living with HIV in Central Asian countries are unaware of being infected. Evidence-informed prevention strategies need to be more widely adopted to control the growing burden of HIV in Central Asia. This output will conduct assessments in each participating country on vulnerabilities of populations at risk to access services, which is a critical hurdle for many HIV/AIDS-infected people. Moreover, the implementation of standard operating procedures for implementation of core interventions such as needle and syringe programs and HIV testing and counseling will be supported under this output. Capacity development events to strengthen implementation of the European Action Plan for HIV/AIDS will be conducted and will also serve as platforms for knowledge exchange across the region.

In line with the approach of strengthening health systems rather than working on single diseases, the output will strengthen surveillance and control of vaccine-preventable diseases. This TA will support implementation and strengthening of case-based surveillance, and support establishment and capacity development of a national verification commission for measles and rubella elimination in each participating country.

Output 3: Improved coordination and collaboration among participating countries and development partners in planning for and responding to communicable diseases. The IHR provides an excellent framework to strengthen coordination and collaboration across sectors within the region and among development partners. One of the key principles promoted through the IHR is that public health surveillance and response should not interfere with international traffic and trade (Art. 2 IHR). To be able to reach this goal, countries are requested to develop and strengthen certain health system capacities for surveillance and response, especially at ports, airports, and ground crossings. The IHR also provides instruments to assess cross-border public health risks in a standardized manner and encourages bilateral and regional collaboration, regional disease surveillance initiatives, coordinated disaster management, and harmonization of legal and regulatory frameworks for transport.

TA activities under output 3 include training national public health experts, improved coordinated surveillance systems, increased cross-sector collaboration, and development of cross-border standards and procedures at border crossings. The TA will strengthen awareness and advocacy efforts on the importance of the IHR beyond the health sector, particularly in the transport and trade sector. The TA will also provide guidance notes in local languages. Multisector coordination and coordination between points of entry and the national level will be improved through awareness-raising activities for senior officials within the health sector and beyond, in order to increase political commitment to IHR implementation. Regional features on IHR core capacity development reported by WHO European member states through the 2011 self-assessment questionnaire will be taken into account in the capacity development activities under this TA.

Project Rationale and Linkage to Country/Regional Strategy

Health is a public good, which impacts beyond the individual, household, or national level. Strategy 2020 highlights that the Asian Development Bank (ADB) should mitigate the adverse health impacts of all of its infrastructure and trade facilitation projects, and should use its comparative advantage in supporting regional public goods and the cross-border nature of health. This is especially so given the increasing mobility within and integration of Central Asia, and the increased risk and consequence of cross-border health issues, new and reemerging communicable diseases and HIV/AIDS being good examples.

ADB is prepared to provide leadership and assistance for regional public goods, i.e., communicable disease control and prevention, and strengthening regional health security in Central Asia Regional Economic Cooperation (CAREC) countries. The severe acute respiratory syndrome crisis and avian influenza events provide extensive evidence that developing member countries (DMCs) look to ADB to provide leadership in regional approaches; advise on preparedness and capacity building; and, where necessary, respond to emergencies and longer-term preparedness.

The CAREC 2020 strategic framework emphasizes infrastructure development and trade facilitation. It also promotes building capacity on regional public goods, such as communicable disease control and disaster risk management, and provides for capacity building, research, and knowledge products as it aims to strengthen its knowledge pillar.

Partnerships will play an increasingly important role in promoting public goods. This proposed technical assistance (TA) provides an excellent opportunity for ADB to complement the acknowledged technical leadership role of agencies such as the World Health Organization (WHO) and facilitate cross-sector collaboration, and therefore enhance the development impacts of strengthened regional health security.

The TA will strengthen the capacity of DMCs in Central and West Asia to prevent and respond to communicable diseases and enhance implementation of the International Health Regulations (IHR).

Impact Decreased incidence of communicable diseases in participating Central Asian countries
Project Outcome
Description of Outcome Strengthened core capacity for surveillance and response to communicable diseases in pilot countries in line with IHR
Progress Toward Outcome --
Implementation Progress
Description of Project Outputs

1. Mapping of communicable disease vulnerability and response conducted in each participating country

2. Improved and standardized communicable disease surveillance and control in participating countries

3. Improved coordination and collaboration among participating countries and development partners in planning for and responding to communicable diseases

Status of Implementation Progress (Outputs, Activities, and Issues)

Completed recruitment of Technical Assistance Program Officer

Ongoing recruitment of consulting firm to provide international and national consultants in participating DMCs

Geographical Location
Summary of Environmental and Social Aspects
Environmental Aspects
Involuntary Resettlement
Indigenous Peoples
Stakeholder Communication, Participation, and Consultation
During Project Design Consultations with the Ministries of Health, other relevant government agencies and other stakeholders were carried out in Tajikistan and Kyrgyz Republic in September 2012. The government agencies indicated their interest in working with ADB on prevention and control of communicable diseases.
During Project Implementation National and regional consultations with various stakeholders will be carried out during project implementation.
Business Opportunities
Consulting Services

The TA will require 15 person-months of international consultants and 72 person-months of national consultants:

International Consultants

1. HIV/AIDS and Communicable Disease Expert (3 person-months, intermittent)

2. Public Health Expert and Epidemiologist (5 person-months, intermittent)

3. Public Health Communication Specialist (2 person-months, intermittent)

4. Border Health Security Expert (2 person-months, intermittent)

5. Public Health Expert (3 person-months, intermittent)

National Consultants

1. Technical Assistance Program Officer (Public Health Expert) (12 person-months, intermittent, based at ADB HQ)

2. Implementation Consultants (5 consultants, 12 person-months each, intermittent)

Procurement Syringes and needles, and HIV testing materials.
Responsible ADB Officer Shanny Campbell
Responsible ADB Department Office of the Director General, CWRD
Responsible ADB Division Portfolio, Results, Safeguards and Social Sector Unit, CWRD
Executing Agencies
Asian Development Bank6 ADB Avenue, Mandaluyong
Metro Manila, Philippines
P.O. Box 789, 1099 Manila,
Philippines
Timetable
Concept Clearance 30 Oct 2012
Fact Finding 04 Feb 2013 to 02 Mar 2013
MRM -
Approval 09 May 2013
Last Review Mission -
Last PDS Update 27 Mar 2014

TA 8367-REG

Milestones
Approval Signing Date Effectivity Date Closing
Original Revised Actual
09 May 2013 - 09 May 2013 31 Dec 2015 - -
Financing Plan/TA Utilization Cumulative Disbursements
ADB Cofinancing Counterpart Total Date Amount
Gov Beneficiaries Project Sponsor Others
0.00 0.00 0.00 0.00 0.00 0.00 0.00 09 May 2013 9,241.52

Safeguard Documents

See also: Safeguards

No documents found.

Evaluation Documents

See also: Independent Evaluation

No documents found.


The Public Communications Policy (PCP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.

Requests for information may also be directed to the InfoUnit.